Clinical trials
Withdrawn Phase 1 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Roswell Park Cancer Institute | 3 |
| Washington University School of Medicine | 3 |
| Mayo Clinic | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Alabama at Birmingham | 2 |
| Acrotech Biopharma Inc. | 1 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| AstraZeneca | 1 |
| Benjamin Movsas, M.D. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 47 |
| Lung Neoplasms | 14 |
| Breast Neoplasms | 6 |
| Ovarian Neoplasms | 5 |
| Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Neoplasm Metastasis | 2 |
| Prostatic Neoplasms | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.